Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1D | P28221 | 8/20 | 1.00 |
| ▸ | HTR1A | P08908 | 6/20 | 1.00 |
| ▸ | HTR1B | P28222 | 6/20 | 1.00 |
| ▸ | HTR6 | P50406 | 5/20 | 1.00 |
| ▸ | HTR2A | P28223 | 4/20 | 1.00 |
| ▸ | HTR2C | P28335 | 3/20 | 1.00 |
| ▸ | HTR7 | P34969 | 3/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | HTR4 | Q13639 | 2/20 | 1.00 |
| ▸ | HTR1E | P28566 | 2/20 | 1.00 |
| ▸ | HTR2B | P41595 | 2/20 | 1.00 |
| ▸ | HTR5A | P47898 | 2/20 | 1.00 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 1.00 |
| ▸ | HTR3B | O95264 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | HTR1F | P30939 | 1/20 | 1.00 |
| ▸ | HTR3A | P46098 | 1/20 | 1.00 |
| ▸ | MTNR1A | P48039 | 1/20 | 1.00 |
| ▸ | MTNR1B | P49286 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mebufotenin SCHEMBL27221706 | 1.00 | HTR1D (1.00) | HTR1DHTR1AHTR1BHTR6HTR2A | |
| Mebufotenin SCHEMBL29351950 | 1.00 | HTR1D (1.00) | HTR1DHTR1AHTR1BHTR6HTR2A | |
| Mebufotenin SCHEMBL31098269 | 1.00 | HTR1D (1.00) | HTR1DHTR1AHTR1BHTR6HTR2A | |
| Mebufotenin SCHEMBL26111484 | 0.99 | HTR1D (0.97) | HTR1DHTR1AHTR1BHTR6HTR2A | |
| Mebufotenin SCHEMBL25330504 | 0.99 | HTR1D (0.97) | HTR1DHTR1AHTR1BHTR6HTR2A | |
| Mebufotenin SCHEMBL7205139 | 0.92 | KMT2A (1.00) | HTR1DHTR1AHTR1BHTR6HTR2A | |
| SCHEMBL8868914 | 0.92 | HTR1D (0.85) | HTR1DHTR1AHTR1BHTR6HTR2A | |
| SCHEMBL24497000 | 0.92 | SLC6A4 (1.00) | HTR1DHTR1AHTR1BHTR6HTR2A | |
| Mebufotenin SCHEMBL29992823 | 0.90 | HTR1D (0.82) | HTR1DHTR1AHTR1BHTR6HTR2A | |
| Mebufotenin SCHEMBL26120710 | 0.90 | HTR1D (0.82) | HTR1DHTR1AHTR1BHTR6HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2295 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144807-A1 | METHOD OF ADMINISTRATION OF A PARENTERAL FORMULATION COMPRISING A PSYCHEDELIC AGENT | CYBIN UK LTD (GB) | 2026-05-28 | — | — | US | claimed |
| CN-122028945-A | Apparatus, systems, and methods for aerosolized drug administration | GH研究爱尔兰有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260124174-A1 | COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | ATAI THERAPEUTICS INC (US) | 2026-05-07 | — | — | US | claimed |
| US-20260115168-A1 | COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | ATAI THERAPEUTICS INC (US) | 2026-04-30 | — | — | US | claimed |
| US-20260114468-A1 | PACKAGED FOOD MIXTURE | CPRG, LLC (US) | 2026-04-30 | — | — | US | claimed |
| US-20260115167-A1 | NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | ATAI THERAPEUTICS INC (US) | 2026-04-30 | — | — | US | claimed |
| US-12612363-B2 | Recrystallisation of 5-methoxy-N,N-dimethyltryptamine(5-MeO-DMT) | GH Research Ireland Limited (IE) | 2026-04-28 | — | — | US | claimed |
| EP-4728531-A1 | BIOADAPTIVE THERAPEUTIC ENVIRONMENTS | Therapod LLC (US) | 2026-04-22 | — | — | EP | claimed |
| EP-4727525-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING 5-METHOXY-N,N-DIMETHYLTRYPTAMINE (5-MEO-DMT) | Beckley Psytech Limited (GB) | 2026-04-22 | — | — | EP | claimed |
| US-12595497-B2 | Processes for the production of tryptamines | COMPASS PATHFINDER LIMITED (GB) | 2026-04-07 | — | — | US | claimed |
| EP-1948155-A2 | PHARMACEUTICAL COMPOSITIONS COMPRISING DROXIDOPA | Chelsea Therapeutics Inc. (US) | 2008-07-30 | — | — | EP | claimed |
| US-20080015181-A1 | Pharmaceutical Compositions Comprising Droxidopa | CHELSEA THERAPEUTICS, INC. | 2008-01-17 | — | — | US | claimed |
| WO-2008003028-A2 | PHARMACEUTICAL COMPOSITIONS COMPRISING DROXIDOPA | CHELSEA THERAPEUTICS, INC. (US) | 2008-01-03 | — | — | WO | claimed |
| WO-2007110637-A1 | METHOD FOR EXTRACTING TARGET ALKALOID USING AN IONIC LIQUID AS EXTRACTING SOLVENT | BIONIQS LIMITED (GB) | 2007-10-04 | — | — | WO | claimed |
| US-7132287-B2 | Preparing culture of nervous system tissues; prepare nutrient broth containing agonist, inoculate with nervous system stem cells, propagate and recover cells | PSYCHIATRIC GENOMICS, INC. (US) | 2006-11-07 | — | — | US | claimed |
| US-20030082802-A1 | Preparing culture of nervous system tissues; prepare nutrient broth containing agonist, inoculate with nervous system stem cells, propagate and recover cells | PSYCHIATRIC GENOMICS, INC. (US) | 2003-05-01 | — | — | US | claimed |
| WO-2002102988-A2 | METHOD FOR NEURAL STEM CELL DIFFERENTIATION USING 5HT-1A AGONISTS | PSYCHIATRIC GENOMICS, INC. (US) | 2002-12-27 | — | — | WO | claimed |
| WO-2001015677-A2 | USE OF 5-HT1B/1D AGONISTS TO TREAT OTIC PAIN | ALCON LABORATORIES, INC. (US) | 2001-03-08 | — | — | WO | claimed |
| WO-1998018458-A1 | OPTHALMOLOGICAL COMPOSITIONS CONTAINING SEROTONIN 5-HT1A RECEPTOR AGONIST AND THEIR USE IN THE TREATMENT OF GLAUCOMA | ALCON LABORATORIES, INC. (US) | 1998-05-07 | — | — | WO | claimed |
| WO-1997044062-A1 | THE USE OF 5-HT1B/1D AGONISTS TO TREAT OCULAR PAIN | ALCON LABORATORIES, INC. (US) | 1997-11-27 | — | — | WO | claimed |